ALBUMIN PROCEDURE, TEKPOINT BROMCRESOL— 510(k) K770451

Substantially Equivalent

Icn Pharmaceuticals, Inc.

FDA 510(k) clearance K770451 for ALBUMIN PROCEDURE, TEKPOINT BROMCRESOL, Substantially Equivalent on 1977-05-03. Applicant: Icn Pharmaceuticals, Inc..

Clearance details

Applicant
Icn Pharmaceuticals, Inc.
Product code
Code CIX
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Orangeburg, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.